Yıl: 2015 Cilt: 15 Sayı: 7 Sayfa Aralığı: 531 - 535 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Coronary slow flow: Benign or ominous?

Öz:
Objective: Coronary slow flow phenomenon has been arbitrarily defined as delayed coronary blood flow in the absence of obstructive coronaryartery disease. The present study sought to investigate the clinical features, natural history, and outcomes of affected patients. Methods: In this prospective cross-sectional study, 217 consecutive patients who had undergone coronary angiography and showed featuresof coronary slow flow phenomenon were evaluated for demographic and coronary risk factor profile, as well as clinical outcomes, at baselineand following treatment. Results: The study population consisted of 165 (76%) males and 52 (24%) females. The mean age of patients was 52.6±10 years. Mean ejectionfraction was 48.2±5.4, 39.3% had diabetes, 43.3% had hypertension, 49.8% was a cigarette smoker, 41.9% had dyslipidemia, and 15% had afamilial history of cardiac disease. Forty-nine percent was detected to have abnormal hsCRP levels. The most prevalent presenting complaintwas atypical chest pain. Fifty-four percent of patients had slow blood flow in all three vessels. Thirty-six people had undergone repeat coronaryangiography in a follow-up period of 5-7 years due to persisting or worsening clinical symptoms, of whom 6 (16.6%) showed significant coronaryartery stenosis. Eight (22.2%) had mild CAD, and the rest still showed coronary slow flow without significant stenosis. The most common com- plaint during follow-up and after initiation of medical therapy was nonanginal chest pain. Conclusion: Patients with coronary slow flow phenomenon are predisposed to atherosclerosis and obstructive coronary artery disease.Therefore, this pathology should not be considered as a totally benign condition. Primary and secondary cardiovasculature preventive mea- sures should be constituted and seem worthwhile in this patient population.
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Li JJ, Wu YJ, Qin XW. Should slow coronary flow be considered as a coronary syndrome? Med Hypotheses 2006; 66: 953-6. [CrossRef]
  • 2. Erdoğan D, Çalışkan M, Güllü H, Sezgin AT, Yıldırır A, Müderrisoğlu H. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis 2007; 191: 168-74. [CrossRef]
  • 3. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries: A new angiographic finding. Am Heart J 1972; 84: 66-71. [CrossRef]
  • 4. Mangieri E, Macchiarelli G, Ciavolella M, Barillá F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathologi- cal features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-81. [CrossRef]
  • 5. Tatlı E, Yıldırım T, Aktöz M. Does coronary slow flow phenomenon lead to myocardial ischemia? Int J Cardiol 2009; 131: 101-2. [CrossRef]
  • 6. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunc- tion in the clinical setting: from mystery to reality. Eur Heart J 2012; 33: 2771-82. [CrossRef]
  • 7. Goel PK‚ Gupta SK‚ Agarwal A‚ Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 2001; 52: 507-14. [CrossRef]
  • 8. Li JJ, Xu B, Li ZC, Qian J, Wei BQ. Is slow coronary flow associated with inflammation? Med Hypotheses 2006; 66: 504-8. [CrossRef]
  • 9. Fineschi M, Bravi A, Gori T. The “slow coronary flow” phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances. Int J Cardiol 2008; 21: 358-61. [CrossRef]
  • 10. Wang X, Geng LL, Nie SP. Coronary slow flow phenomenon: a local or systemic disease? Med Hypotheses 2010; 75: 334-7. [CrossRef]
  • 11. Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow -prevalence and clinical correlations. Circ J 2012; 76: 936-42. [CrossRef]
  • 12. Gökçe M, Kaplan S, Tekelioğlu Y, Erdoğan T, Küçükosmanoğlu M. Platelet function disorder in patients with coronary slow flow. Clin Cardiol 2005; 28: 145-8. [CrossRef]
  • 13. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon-a new coronary microvascular disorder. Cardiology 2002; 97: 197-202. [CrossRef]
  • 14. Pekdemir H, Polat G, Cin VG, Camsarı A, Çiçek D, Akkuş MN‚ et al. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol 2004; 97: 35-41. [CrossRef]
  • 15. Dai YX, Li CG, Huang ZY, Zhong X, Qian JY, Liu XB‚ et al. Clinical and angiographic characteristics of patients with slow coronary flow. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 642-6.
  • 16. Yılmaz MB, Erdem A, Yontar OC, Sarıkaya S, Yılmaz A, Madak N, et al. Relationship between HbA1 c and coronary flow rate in patients with type 2 diabetes mellitus and angiographically normal coronary arteries. Turk Kardiyol Dern Ars 2010; 38: 405-10.
  • 17. Elsherbiny IA. Left ventricular function and exercise capacity in patients with slow coronary flow. Echocardiography 2012; 29: 158-64. [CrossRef]
  • 18. Sezgin AT, Topal E, Barutçu I, Özdemir R, Güllü H, Barışkaner E, et al. Impaired left ventricle filling in slow coronary flow phenome- non: an echo-Doppler study. Angiology 2005; 56: 397-401. [CrossRef]
  • 19. Moazenzadeh M, Abbaszadeh M, Rashidinezhad HR, Sarvar Azimzadeh B. Comparison of plasma level of hs-CRP in subjects with slow coronary flow and normal coronary flow. Iranian Heart Journal 2012; 13: 17-22.
  • 20. Çanga A, Altan Kocaman S, Çetin M, Çetin M, Durakoğlugil E, Erdoğan T, et al. Relationship between leukocyte and subtype counts, low-grade inflammation and slow coronary flow phenom- enon in patients with angiographically normal coronary arteries. Acta Cardiol Sin 2012; 28: 306-14.
  • 21. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, et al. High prevalence of coronary atherosclerosis in asymp- tomatic teenagers and young adults evidence from intravascular ultrasound. Circulation 2001; 103: 2705-10. [CrossRef]
  • 22. Wieneke H, Zander C, Eising EG, Haude M, Bockisch A, Erbel R. Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomography. Herz 1999; 24: 515-21. [CrossRef]
  • 23. Amirzadegan A, Motamed A, Davarpasand T, Shahrzad M, Lotfi- Tokaldany M. Clinical characteristics and mid-term outcomes of patients with slow coronary flow. Acta Cardiol 2012; 67: 583-7.
  • 24. Bonow RO. Braunwald’s Heart Disease. In: Mann DL, Zipes DP, Libby P, editors. Philadelphia: Elsevier Science; 2011.p.897-913.
  • 25. Fan Y, Yang SS, Yu JB, Hao JH, Han W, Gan RT, et al. Atorvastatin use and coronary flow reserve in patients with coronary slow flow. Zhonghua Xin Xue Guan Bing Za Zhi 2010; 38: 143-6.
  • 26. Calışkan M, Erdoğan D, Güllü H, Topçu S, Çiftçi O, Yıldırır A, et al. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol 2007; 30: 475-9. [CrossRef]
  • 27. Albayrak S, Ordu S, Yüksel H, Özhan H, Yazgan O, Yazıcı M. Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow. Int Heart J 2009; 50: 545-53. [CrossRef]
  • 28. Li L, Gu Y‚ Liu T, Bai Y, Hou L, Cheng Z, et al. A randomized, single- center double-blinded trial on the effects of diltiazem sustained- release capsules in patients with coronary slow flow phenomenon at 6-month follow-up. PLoS One 2012; 7: e38851. [CrossRef]
APA SADR AMELI M, SAEDI S, SAEDI T, MADANI M, ESMAEILI M, GHARDOOST B (2015). Coronary slow flow: Benign or ominous?. , 531 - 535.
Chicago SADR AMELI Mohammad Ali,SAEDI Sedigheh,SAEDI Tahereh,MADANI Mohsen,ESMAEILI Mehrdad,GHARDOOST Behshid Coronary slow flow: Benign or ominous?. (2015): 531 - 535.
MLA SADR AMELI Mohammad Ali,SAEDI Sedigheh,SAEDI Tahereh,MADANI Mohsen,ESMAEILI Mehrdad,GHARDOOST Behshid Coronary slow flow: Benign or ominous?. , 2015, ss.531 - 535.
AMA SADR AMELI M,SAEDI S,SAEDI T,MADANI M,ESMAEILI M,GHARDOOST B Coronary slow flow: Benign or ominous?. . 2015; 531 - 535.
Vancouver SADR AMELI M,SAEDI S,SAEDI T,MADANI M,ESMAEILI M,GHARDOOST B Coronary slow flow: Benign or ominous?. . 2015; 531 - 535.
IEEE SADR AMELI M,SAEDI S,SAEDI T,MADANI M,ESMAEILI M,GHARDOOST B "Coronary slow flow: Benign or ominous?." , ss.531 - 535, 2015.
ISNAD SADR AMELI, Mohammad Ali vd. "Coronary slow flow: Benign or ominous?". (2015), 531-535.
APA SADR AMELI M, SAEDI S, SAEDI T, MADANI M, ESMAEILI M, GHARDOOST B (2015). Coronary slow flow: Benign or ominous?. The Anatolian Journal of Cardiology, 15(7), 531 - 535.
Chicago SADR AMELI Mohammad Ali,SAEDI Sedigheh,SAEDI Tahereh,MADANI Mohsen,ESMAEILI Mehrdad,GHARDOOST Behshid Coronary slow flow: Benign or ominous?. The Anatolian Journal of Cardiology 15, no.7 (2015): 531 - 535.
MLA SADR AMELI Mohammad Ali,SAEDI Sedigheh,SAEDI Tahereh,MADANI Mohsen,ESMAEILI Mehrdad,GHARDOOST Behshid Coronary slow flow: Benign or ominous?. The Anatolian Journal of Cardiology, vol.15, no.7, 2015, ss.531 - 535.
AMA SADR AMELI M,SAEDI S,SAEDI T,MADANI M,ESMAEILI M,GHARDOOST B Coronary slow flow: Benign or ominous?. The Anatolian Journal of Cardiology. 2015; 15(7): 531 - 535.
Vancouver SADR AMELI M,SAEDI S,SAEDI T,MADANI M,ESMAEILI M,GHARDOOST B Coronary slow flow: Benign or ominous?. The Anatolian Journal of Cardiology. 2015; 15(7): 531 - 535.
IEEE SADR AMELI M,SAEDI S,SAEDI T,MADANI M,ESMAEILI M,GHARDOOST B "Coronary slow flow: Benign or ominous?." The Anatolian Journal of Cardiology, 15, ss.531 - 535, 2015.
ISNAD SADR AMELI, Mohammad Ali vd. "Coronary slow flow: Benign or ominous?". The Anatolian Journal of Cardiology 15/7 (2015), 531-535.